The total return over the past 12 months is +82.10% vs. +16.94% for the S&P 500. So far it's up +35.82% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +82.10% | +42.90% | +44.28% | N/A | N/A | N/A |
| Total Return CAGR | +82.10% | +42.90% | +44.28% | N/A | N/A | N/A |
| Revenue CAGR | +22.63% | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | +64.57% | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | +62.16% | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | +39.01% | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +39.38% | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Krystal Biotech, Inc. (KRYS)
| Year | Start price | End price | KRYS Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $246.54 | $334.85 | +35.82% | +14.51% | +21.31% |
| 2025 | $156.66 | $246.54 | +57.37% | +17.72% | +39.65% |
| 2024 | $124.06 | $156.66 | +26.28% | +24.89% | +1.39% |
| 2023 | $79.22 | $124.06 | +56.60% | +26.19% | +30.41% |
| 2022 | $69.95 | $79.22 | +13.25% | (18.17%) | +31.42% |
| 2021 | $60.00 | $69.95 | +16.58% | +28.74% | (12.16%) |
| 2020 | $55.38 | $60.00 | +8.34% | +18.37% | (10.03%) |
| 2019 | $20.78 | $55.38 | +166.51% | +31.22% | +135.29% |
| 2018 | $10.52 | $20.78 | +97.53% | (4.56%) | +102.09% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
